NEW YORK (GenomeWeb) — HTG Molecular Diagnostics reported after the close of the market on Tuesday a 172 percent year-over-year increase in its second quarter revenues, largely due to its collaborative development services activities with pharmaceutical partners.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.